A nanobody-based tri-specific NK cell engager targeting CD5 triggers antitumor immunity
Summary: The poor prognosis of patients with recurrent or refractory T cell malignancies emphasizes the need for improved immunotherapies. CD5 is a characteristic marker of malignant T cells and is expressed on almost all normal T cells. Therefore, for treating T cell malignancies, focusing on natur...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-10-01
|
| Seri Bilgileri: | Cell Reports Medicine |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S2666379125004823 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|